Patient-Reported Outcomes in Metastatic Breast Cancer: A Review of Industry-Sponsored Clinical Trials
Introduction Patient-reported outcome (PRO) measures serve to capture vital patient information not otherwise obtained by primary study endpoints. This paper examines how PROs are utilized as endpoints in industry-sponsored metastatic breast cancer clinical trials. Methods A search was conducted in...
Main Authors: | Meaghan Krohe, Yanni Hao, Roger E. Lamoureux, Nina Galipeau, Denise Globe, Catherine Foley, Iyar Mazar, Jeffrey Solomon, Alan L. Shields |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2016-01-01
|
Series: | Breast Cancer: Basic and Clinical Research |
Online Access: | https://doi.org/10.4137/BCBCR.S39385 |
Similar Items
-
Patient-Reported Outcomes in Metastatic Breast Cancer: A Review of Industry-Sponsored Clinical Trials
by: Meaghan Krohe, et al.
Published: (2016-07-01) -
Fatherhood at Work and at Home: An analysis of men's joint identifications with parenting and work
by: Mazar, Iyar
Published: (2012) -
"On a good day no one knows": Management of disease impacts in Barth Syndrome
by: Mazar, Iyar
Published: (2019) -
Content validity of the National Comprehensive Cancer Network – Functional Assessment of Cancer Therapy – Breast Cancer Symptom Index (NFBSI-16) and Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function Short Form with advanced breast cancer patients
by: Meaghan Krohe, et al.
Published: (2019-05-01) -
Understanding key symptoms, side effects, and impacts of HR+/HER2- advanced breast cancer: qualitative study findings
by: Nina Galipeau, et al.
Published: (2019-02-01)